DarioHealth Corp. (NASDAQ: DRIO)

DarioHealth Corp is a vertically integrated health intelligence platform that delivers a whole person digital health solution. The company combines FDA cleared hardware devices that generate continuous physiological data with proprietary artificial intelligence and behavior change coaching to support chronic condition management mental health and musculoskeletal wellness.

DarioHealth generates revenue primarily through a subscription model that charges per member per month or per engaged member per month for its digital health offerings. The company sells products such as Dario Connect for well being Dario Mind for mental health Dario Health for diabetes and hypertension Dario Health for weight management and GLP 1 support and Dario Move for musculoskeletal care. These subscriptions may be bundled or sold individually and can include milestone based payments or performance guarantees. Revenue is earned from direct to consumer users as well as from business to business customers including employers health plans and pharmaceutical companies.

The company operates through the following segments: Direct to Consumer Employer Health Plan Pharmaceutical.

• The Direct to Consumer segment offers digital self care tools and connected devices to individuals who pay out of pocket for wellness and chronic condition management. It serves as a testing ground for new features and builds engagement through personalized content and coaching.

• The Employer segment provides medium to large employers with workforce health solutions that target diabetes hypertension weight management and musculoskeletal pain. It includes direct sales broker and consultant channels and often uses value based pricing tied to employee engagement and clinical outcomes.

• The Health Plan segment supplies national and regional health plans with programs that support members across chronic disease mental health and preventive care. Delivery is through the plan s own sales force and through partners and may incorporate fee for service or subscription payments.

• The Pharmaceutical segment works with global drug makers to provide disease awareness medication adherence support and patient journey analytics. It uses the platform to help find new patients improve therapy persistence and generate real world evidence for research and development.

DarioHealth holds a strong position in the digital health market by offering a fully integrated platform that combines hardware data analytics and coaching across multiple conditions. This whole person approach differentiates it from pure software competitors and from narrow point solution vendors such as Omada Health Vida Health Virta Health and Teladoc Health. The company s competitive advantages stem from its direct to consumer roots which drive high engagement its proprietary AI trained on over a decade of device generated data and its ability to bundle services while preserving customer flexibility. These factors enable DarioHealth to deliver returns on investment that frequently exceed five to one for employers health plans and pharmaceutical partners.

DarioHealth serves a diverse customer base that includes individual consumers who purchase products directly as well as large employers health plans and pharmaceutical firms. Specific customers mentioned in the filing are three of the five largest global technology companies one of the two largest employers in the United States five of the nation s largest health plans and a dozen global pharmaceutical companies including Eli Lilly and Novo Nordisk.